
(she/her/hers) | GC | MSL Director | opinions are my own |#lgbtqiaally #blm #gcswithdisabilities #genechat
Bridgewater, NJ
Joined January 2011
- Tweets1.6K
- Following1.3K
- Followers725
- Likes2.2K
Lauren Giannetti Sferrazza MS, LGC retweeted
Cheers, chills, and a standing ovation when RASolute 302 showed unprecedented survival on daraxonrasib for patients with progressive pancreatic cancer
Seldom do you sense you’re witnessing a historic moment in cancer care but this feels like ras targeting has arrived
#ASCO26
It feels good to be back! My first ASCO with @adela_bio and post-baby . I’m absorbing all the amazing content and trying to connect with my peers and clinicians! #asco26 #tissuefreemrd
Lauren Giannetti Sferrazza MS, LGC retweeted
Adela is advancing methylome analysis to deliver sensitive, blood-based ctDNA testing options for patients with cancer. By enabling earlier detection and more precise monitoring of cancer, we help clinicians and biopharma partners make more confident, informed decisions
#ASCO26
Lauren Giannetti Sferrazza MS, LGC retweeted
We’re excited to share that Adela will highlight progress from our MCED study @ASCO 2026.
prnewswire.com/news-releases…
#ASCO26
Lauren Giannetti Sferrazza MS, LGC retweeted
New Updates on Recurrence Detection in Head and Neck Cancer - Elizabeth Lightbody
@adela_bio
oncodaily.com/voices/elizabe…
#OncoDaily #ASCO
Lauren Giannetti Sferrazza MS, LGC retweeted
Happy Thursday, #MHNCS26! Day 1's highlights include the first Keynote from Sana Karam, MD, PhD, a Patient Perspective from Hector Basham, the K. Kian Ang, MD, PhD, FASTRO, Commemorative Plenary Session, and more!
View the schedule: ow.ly/FrTg50Yielh
We love seeing a #geneticcounselor as a top leader! Congrats! @GeneticCouns
Sheetal Parmar, SVP of medical affairs, women’s health, has been recognized as one of the 2025 Top 50 Women Leaders in Healthcare Technology by The Healthcare Technology Report. 👏 The annual distinction highlights leaders who are shaping the future of healthcare through scientific advancement, operational excellence and meaningful patient impact.
Since joining Natera in 2013, Sheetal has been instrumental in strengthening the clinical foundation of our women’s health portfolio. A board-certified genetic counselor specializing in prenatal diagnosis and screening, she leads a multidisciplinary medical affairs organization and plays a critical role in guiding clinical strategy, enhancing the design and execution of the clinical trials and shaping Natera's approach to educating and serving patients and their providers. Her leadership reflects a deep commitment to advancing standards of care and expanding access to innovative genetic testing.
Please join us in congratulating Sheetal on this outstanding achievement!
ow.ly/Yip350YhCJC
Lauren Giannetti Sferrazza MS, LGC retweeted
Gearing up for a packed first day of exciting presentations at #MHNCS26! @ASTRO_org
Another great poster from @myriadgenetics - reporting the HRD status of patients in a research registry #sgomeeting #sgo25
So proud of @myriadgenetics poster from our patient registry - check out our poster on the prevalence of germline PVs in EC >50 #SGOMtg #sgo2025 #myriadgenetics #hereditarycancer
Having a serious case of FOMO while on mat leave during #SGOMtg #sgo2025 thanks to @ShannonWestin I feel like I’m right there with everyone !!!
🔥♥️🤩👏Inspiring talk to #MultiplyYourImpact by @amandanfader at #SGOMtg #SGO2025
🔥🔥🔥An awesome @SGO_org president in a time of uncertainty!!!
Lauren Giannetti Sferrazza MS, LGC retweeted
🔥🔥Hear our @SGO_org expert Dr. Kathleen Moore discuss #impact of DUO-E regimen in MMR-proficient #endometrialcancer with biomarker stratification @ShannonWestin @amandanfader #SGOMtg #SGO2025
Lauren Giannetti Sferrazza MS, LGC retweeted
📢For #BlackHistoryMonth, we are highlighting @BlackInGenetics, an organization “dedicated to amplifying the voices and work of Black-identifying geneticists across the U.S”
➡️Learn more 👉blackingenetics.com/
#AdvancingCommitments #HereditaryGICancer
@yvonnerms @LGtheCGC




























